Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

《当代阿尔茨海默病研究》发表同行评审的前沿综述、研究、药物临床试验研究和关于阿尔茨海默病各个领域的信件文章。这本多学科期刊将有助于了解阿尔茨海默病的神经生物学、遗传学、发病机制和治疗策略。该期刊发表由积极从事细胞、分子和动物模型研究的专家和领导者撰写的客观评论。该期刊还涵盖了分子诊断、脑成像、药物开发和发现以及阿尔茨海默病临床方面的快速新兴领域的最新研究的原创文章。鼓励提交与阿尔茨海默病与其他痴呆和神经退行性疾病的协同机制相关的手稿。还发表书评、会议报告和致编辑的信。对于对与年龄有关的痴呆和阿尔茨海默病感兴趣的研究人员、教育工作者和医生来说，这本期刊是必读之作。 《当前阿尔茨海默病研究》为神经科学家、临床医生、健康科学规划人员、授权人、护理人员以及这种毁灭性疾病的患者家属提供了阿尔茨海默病研究现状的全面“鸟瞰图”。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-神经科学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为1.8，平均审稿速度为 偏慢,4-8周 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。